Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
12/2005
12/28/2005EP1173433B1 Cyanopyrroles as progesterone receptor agonists
12/28/2005EP1129089B1 Spiro-indolines as y5 receptor antagonists
12/28/2005EP1124810B9 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents
12/28/2005EP0991660B1 DEUTERATED and undeuterated CYCLOSPORINE ANALOGS AND THEIR USE AS IMMUNOMODULATING AGENTS
12/28/2005EP0778836B1 Substituted 9-alkyladenines
12/28/2005CN1714092A Thieno[3,2-b]pyridine-6-carbonitriles and thieno[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors
12/28/2005CN1714084A Pyrimidine-2,4,6-trione metalloproteinase inhibitors
12/28/2005CN1233385C Medicine for treating uraemia
12/28/2005CN1233383C Chinese medicinal preparation for treating prostate disease and its preparation method
12/28/2005CN1233382C Medicine for internal organ diseases
12/28/2005CN1233347C Prostatosis treating pill made of 18 kinds of Chinese medicine material
12/28/2005CN1233346C Novel medicine for treating urinary retention and preparing method thereof
12/28/2005CN1233340C Chinese medicine dialysate for maintenance hemodialysis of chronic renal failure, and preparing method thereof
12/28/2005CN1233334C Oral liquid for detoxicating and dispelling wind
12/27/2005US6979696 Method for detecting a gram-negative bacterial autoinducer molecule
12/27/2005US6979691 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
12/27/2005US6979683 Polymerase enzyme inhibitors
12/22/2005WO2005121112A1 Medicinal compositions containing 6-hydroxybenz- bromarone or salts thereof
12/22/2005WO2005120530A1 Composition for prevention and treatment of urinary incontinence
12/22/2005WO2005097814A3 Composition and method for inhibiting platelet aggregation
12/22/2005WO2002083874A3 Endothelial cell expression patterns
12/22/2005US20050283844 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
12/22/2005US20050282889 Intracorporeal medicaments for photodynamic treatment of disease
12/22/2005US20050282882 Diamines as modulators of chemokine receptor activity
12/22/2005US20050282875 Pyrrolidinium derivatives
12/22/2005US20050282867 Hydrochloride salt of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazo-lidine-2,4-dione
12/22/2005US20050282861 Sulfonamide-containing benzene derivatives; cancer and inflammatory, immunomodulatory or respiratory diseases; allergy, seasonal allergic rhinitis, reversible airway obstruction, adult respiratory distress syndrome, asthma, or bronchitis
12/22/2005US20050282798 Pharmaceutical compounds
12/22/2005US20050282789 administering for treatment of metabolic bone diseases, mobilizing calcium for osteoporosis, imbalances in the immune system
12/22/2005US20050282236 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
12/22/2005US20050282157 Using oligonucleotide and peptide nucleic acid oligomers for use as diagnostic tool in monitoring cytosine methylation; detecting cell proliferative, inflammatory, connective, bone, nervous system and cardiovascular disorders
12/22/2005US20050281818 Method for the treatment of fibrosis
12/22/2005US20050281807 Use of C-reactive protein to treat immune complex-mediated renal disease
12/21/2005EP1607744A2 Treatment of diseases involving cyst formation with combinations comprising a PTBR agonist
12/21/2005EP1606307A1 ESTRIENO(3,2-b)/(3,4-c)PYRROLE DERIVATIVES USEFUL AS MODULATORS OF THE ESTROGEN RECEPTORS
12/21/2005EP1576086A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
12/21/2005EP1463728A4 Fused cyclic modulators of nuclear hormone receptor function
12/21/2005EP1458723A4 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function
12/21/2005EP1432701B1 Heterocyclic compounds for use in the treatment of disorders of the urinary tract
12/21/2005EP1395558B1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
12/21/2005EP1389205B1 Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders
12/21/2005EP1377567B1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
12/21/2005EP1363897B1 Antagonists of mcp-1 function and methods of use thereof
12/21/2005EP1265859B1 Amidino compounds useful as nitric oxide synthase inhibitors
12/21/2005EP1178973B1 Pyrazinyl-piperazine- compounds, their use and preparation
12/21/2005EP1144431B1 16-hydroxyestratrienes as selective estrogens
12/21/2005EP0579819B1 Novel pyridone derivative having an affinity for the angiotensine ii receptor
12/21/2005CN1711085A Remedy for overactive bladder comprising acetic acid anilide derivative as the active ingredient
12/21/2005CN1232520C Salts of bicyclic N-acylated imidazo-3-amines and imidazo-5-amines
12/21/2005CN1232507C Growth hormone secretagogues
12/21/2005CN1232292C Chinese medicine for treating prostatitis
12/21/2005CN1232275C Enteroclysis liquid medicine for treating renal failure and its prepn. method
12/21/2005CN1232272C Haigou-shenlong pill
12/21/2005CN1232268C New use of compound Chinese medicine for warming spleen
12/21/2005CN1232260C Application of fungus polysaccharide sulfate in the preparation of chronic nephritis and kidney failure treating medicine
12/20/2005US6977267 Spiro-hydantoin compounds useful as anti-inflammatory agents
12/20/2005US6977264 For therapy and prophylaxis of obesity, diabetes
12/20/2005US6977256 Compounds and compositions as cathepsin S inhibitors
12/15/2005WO2005118811A1 Novel polypeptide useful for diagnosis and treatment of cancer
12/15/2005WO2005118556A1 Propane-1,3-dione derivative or its salt
12/15/2005WO2005118543A1 Kinase inhibitor and use thereof
12/15/2005WO2005117901A1 Oral formulations of paricalcitol
12/15/2005US20050277678 5-(4-Fluorophenyl)-1-(4-methylsulfoximinylphenyl)-3-trifluoromethyl-1H-pyrazole; prostaglandin and cyclooxygenase inhibitor; antiinflammatory, analgesic, and antipyretic agent
12/15/2005US20050277652 Hepatocyte growth factor receptor inhibitors; Antitumor agents, anticarcinogenic agents, angiogenesis inhibitors; pyrimidine derivatives like Pyrrolidine-1-carboxylic acid [6-(2-fluoro-4-{3-[2-(4-fluorophenyl)acetyl]thioureido}phenoxy)pyrimidin-4-yl]amide
12/15/2005US20050277646 N-[4-({5-(4-fluorophenyl)-4-[4-(trifluoromethyl)phenyl]pyridin-2-yl}oxy)-1,3-benzothiazol-2-yl]acetamide; vanilloid (capsaicin) receptor antagonist/agonist; antiinflammatory, analgesic, antiarthritis, antirheumatic; diseases involving sensory nerve function
12/15/2005US20050277627 Colchinol derivatives as vascular damaging agents
12/15/2005US20050277606 Administering by direct injection into heart an expression vector comprising a nucleic acid sequence encoding AOP-1 operably linked to a promoter, wherein expression of nucleic acid sequence within cells of heart enhances production of AOP-1, protecting against myocardial cell death
12/15/2005US20050277594 Polypeptide for the treatment of cancer and a method for preparation thereof
12/15/2005US20050276821 Antigen protein and nucleic acid coding for said protein
12/15/2005US20050276789 Immunostimulatory oligonucleotides and uses thereof
12/15/2005DE202005013718U1 Natural medicament, useful for dehydrating the body in persons with kidney disorders and limited kidney function, comprises extracts of onion peel, vitamins and trace elements
12/15/2005CA2578806A1 Oral formulations of paricalcitol
12/14/2005EP1604983A1 Receptor antagonist
12/14/2005EP1604982A1 Intermediates for the preparation of piperidine derivatives useful as modulators of chemokine receptor activity
12/14/2005EP1604674A2 Use of myoblasts in the manufacture of a medicament for treating stress urinary incontinence
12/14/2005EP1604664A1 Medicine for prevention of and treatment for arteriosclerosis and hypertension
12/14/2005EP1604653A1 Acetylcholinesterase inhibitors for improving excretory potency of urinary bladder
12/14/2005EP1603578A2 Cystitis treatment with high dose chondroitin sulfate
12/14/2005EP1242104B1 Process of obtaining thylakoids from plants, pure thylakoids and use thereof
12/14/2005EP1112255B1 4,4-biarylpiperidine derivatives with opioid receptor activity
12/14/2005CN1231479C Naphthostyrils compounds
12/14/2005CN1231474C Salts of aiso thiazole-4-carboxamide and their use as anti-hyperproliferatin agents
12/14/2005CN1231471C 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhbitors of cell-cycle kinases
12/14/2005CN1231461C Bicyclo [2.2.1] heptanes and related compounds
12/14/2005CN1231458C Novel aryloxy-alkyl-dialkylamines compound
12/14/2005CN1231256C Non-aqueous proton peptide formulations
12/14/2005CN1231212C Multicyclic compounds which inhibit beukocyte adhesion mediated by VLA-4
12/13/2005US6974836 Diamines as modulators of chemokine receptor activity
12/13/2005US6974813 For therapy of perioperative myocardial ischemic injury in mammals, including humans
12/08/2005WO2005115993A1 Quinazoline derivative
12/08/2005WO2005054432A3 Gene transfer for regulating smooth muscle tone
12/08/2005WO2003060148A3 Androgen regulated nucleic acid molecules and encoded proteins
12/08/2005US20050272936 Imidazolium cxcr3 inhibitors
12/08/2005US20050272931 Vanilloid receptor ligands and their use in treatments
12/08/2005US20050272796 Prevention and treatment of benign prostatic hyperplasia using lonidamine and lonidamine analogs
12/08/2005US20050272795 Prevention and treatment of benign prostatic hyperplasia
12/08/2005US20050272761 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders
12/08/2005US20050272733 1-substituted pyridine-2-ones or 2-substituted pyridazin-3-ones; anticarcinogenic agents for breast and prostate cancer; contraceptives; endometriosis, benign prostatic hypertophy
12/08/2005US20050272718 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
12/08/2005US20050272715 Optically active dihydropyridine derivative
1 ... 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 ... 562